Connect with us

Hi, what are you looking for?


Pro-life groups assail FDA for ‘reckless disregard’ in Supreme Court abortion pill case

Pro-life leaders are accusing the Food and Drug Administration (FDA) of operating with a ‘reckless disregard for women’s health and safety’ over the agency’s handling of a controversial abortion pill that’s now at the center of a high-stakes high court case.

The U.S. Supreme Court on Tuesday heard arguments in a case that could curb nationwide access to abortion pills such as mifepristone — the drug that’s drawn the ire of the pro-life community, including March for Life President Jeanne Mancini. 

‘The FDA’s removal of nearly all safeguards around the dangerous abortion drug mifepristone has needlessly put women and girls at risk for suffering severe — even life-threatening — complications without the ongoing care of a medical provider,’ Mancini said. ‘We hope the FDA will be held accountable for failing to meet its own standards when it comes to abortion drugs. Such reckless disregard for women’s health and safety is unacceptable from an agency tasked with protecting it.’

The case, FDA v. Alliance for Hippocratic Medicine, centers around mifepristone. Approved by the FDA in 2000, the medication is used alongside another drug to end a pregnancy as early as 10 weeks gestation.

The FDA took strides in 2021 — the year before the Supreme Court’s June 2022 ruling that overturned Roe v. Wade — to make mifepristone more accessible, including by removing the requirement for patients to see a doctor in person to get a prescription. 

But months after the Supreme Court’s landmark summer decision, a federal appeals court in Texas ruled the FDA’s policy change was illegal, as was an earlier update that extended the pill’s recommended usage by several weeks. The high court is now reviewing that decision.

‘Bowing to pressure from the abortion industry, the FDA loosened the safety requirements of mifepristone which still has a black box warning,’ National Right to Life President Carol Tobias said. ‘Drugs that come with black box warnings have the most dangerous side effects and safety concerns, yet the FDA is okay with mifepristone being prescribed and even mailed to women without an in-person exam.’

SBA Pro-Life America President Marjorie Dannenfelser told Fox News Digital that she ‘was proud to stand with women harmed by abortion drugs courageously sharing their stories, and with the doctors caring for them, in contrast to the abortion industry that leaves women to suffer alone.’

‘Today we are standing up to say women’s health matters and the FDA must do its job. We urge the Supreme Court to uphold safeguards for women and girls,’ she said.

Erik Baptist, senior counsel of Alliance Defending Freedom, said that pro-life groups are ‘simply asking the Court to reinstate the original standards that were in effect for over 15 years.’

Meanwhile, pro-choice groups are maintaining that mifepristone is a safe and critical drug in the post-Roe landscape of reproductive health.

‘Decades of research and clinical experience have demonstrated that mifepristone is extraordinarily safe and effective, including when dispensed by pharmacies or through the mail,’ Rabia Muqaddam, senior staff attorney at the Center for Reproductive Rights, told Fox News Digital. ‘There is no legitimate science disputing this research. Instead, the plaintiffs in the case rely on widely discredited and even retracted research articles and the say-so of anti-abortion zealots.’

Muqaddam added: ‘If the Supreme Court sides with the plaintiffs and their junk science over the FDA and decades of high-quality research, countless people will suffer as will the ability of Americans to access important drug innovations.’

Planned Parenthood President Alexis McGill Johnson cast the case as a ‘threat’ to women’s rights — and more.

‘Beyond the threat to our fundamental rights, the very existence of this case puts every other FDA-approved medication at risk of being taken off the market or restricted for political reasons,’ Johnson said. ‘That is reason enough to be clear about how serious this case is for the future of sexual and reproductive health care and everything beyond.’

This post appeared first on FOX NEWS

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



A recent report from SoSoValue shows significant movements in the Bitcoin exchange-traded funds (ETFs) market, mainly focusing on the outflows observed in Grayscale’s Bitcoin Trust (GBTC)...


Clearstream, Deutsche Börse’s post-trade business is investing an undisclosed amount in the fintech start-up Digital Vault Services (DVS). Deutsche Börse, one of Europe’s biggest...


According to a CoinDesk report, OKX, the world’s second-largest cryptocurrency exchange by trading volume, has lost two of its top executives, Tim Byun and...


The foreign aid plan Speaker Johnson, R-La., unveiled on Monday night is already facing a growing red wave of opposition from his own colleagues...


Russian President Vladimir Putin joined international calls for cool heads in the Middle East as tensions remain high following Iran’s unprecedented attack on Israel...


A nonprofit founded and funded by liberal billionaire George Soros funneled a massive eight-figure sum into a prominent liberal super PAC that bankrolls several...

You May Also Like

Financial Advisors


Financial Advisors


Financial Advisors

The humongous outbreak of the dreaded coronavirus has brought about a groundbreaking change in what the world perceived as ‘normal’. With an estimated 280,391,189...

Disclaimer: Respect, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 Respect Investment. All Rights Reserved.